Abstract | BACKGROUND: METHODS: We generated transgenic mice, called pS2-dnRII or ITF-dnRII, of which the dominant negative mutant of the TGF-beta type II receptor was expressed under the control of tissue-specific promoters, the pS2 promoter for stomach and ITF for intestine. They were either infected with H.pylori (ATCC 43504 strain, CagA+ and VacA+) or administered with azoxymethane to determine the significance of loss of TGF-beta signalling in gastrointestinal carcinogenesis. RESULTS: CONCLUSIONS: Maintaining normal TGF-beta signalling in the gastrointestinal tract seems to be important either for preventing abnormal mucosal proliferation, or for suppressing or retarding carcinogenesis.
|
Authors | K-B Hahm, K M Lee, Y B Kim, W S Hong, W H Lee, S U Han, M W Kim, B O Ahn, T Y Oh, M H Lee, J Green, S J Kim |
Journal | Alimentary pharmacology & therapeutics
(Aliment Pharmacol Ther)
Vol. 16 Suppl 2
Pg. 115-27
(Apr 2002)
ISSN: 0269-2813 [Print] England |
PMID | 11966532
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Carcinogens
- Receptors, Transforming Growth Factor beta
- Transforming Growth Factor beta
- Azoxymethane
|
Topics |
- Animals
- Azoxymethane
(toxicity)
- Carcinogens
(toxicity)
- Carcinoma
(etiology, genetics, metabolism, pathology)
- Colonic Neoplasms
(genetics, metabolism, pathology)
- Disease Susceptibility
- Gastritis
(etiology, genetics, metabolism, pathology)
- Helicobacter Infections
(complications, genetics, metabolism, pathology)
- Helicobacter pylori
- Mice
- Mice, Transgenic
- Receptors, Transforming Growth Factor beta
(genetics, metabolism)
- Signal Transduction
- Stomach Neoplasms
(etiology, genetics, metabolism, pathology)
- Transforming Growth Factor beta
(genetics, metabolism)
|